CUSIP 68062P106COMOLMAQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
200 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bain Capital Life Sciences Investors, LLC | 8.51M | $212.72M | +1.66M | Added |
| 2 | Paradigm Biocapital Advisors LP | 7.54M | $188.60M | +750.0K | Added |
| 3 | Janus Henderson Group PLC | 6.71M | $167.90M | +3.12M | Added |
| 4 | Blackrock, Inc. | 5.56M | $139.08M |
| +836.9K |
| Added |
| 5 | Bvf Inc/Il | 5.30M | $132.40M | 0 | Held |
| 6 | Fmr LLC | 5.02M | $125.58M | +4.99M | Added |
| 7 | Vanguard Group Inc | 3.56M | $89.03M | +364.0K | Added |
| 8 | Siren, L.L.C. | 3.30M | $82.52M | +3.30M | New |
| 9 | Logos Global Management LP | 3.21M | $80.22M | 0 | Held |
| 10 | Cormorant Asset Management, LP | 2.75M | $68.75M | +2.75M | New |
See every fund holding Olema Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders